The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Padmanaban Krishnamoorthy
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved in line with Nifty Microcap 250 and 0.2 pts more than its Pharmaceuticals & Biotechnology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Mr. Padmanaban Krishnamoorthy, part of the promoter group, acquired 64,33,700 equity shares (49.49%) of Genesis IBRC India Limited through an off-market inter-se transfer by way of gift from an immediate relative (spouse) on January 19, 2026. His personal holding in the company rose from 16,36,700 shares (12.59%) to 80,70,400 shares (62.08%). The transaction is exempt under Regulation 10(1)(a)(i) of SEBI Takeover Regulations, 2011, and the total shareholding of the Promoter and Promoter Group remains unchanged. The total paid-up share capital of the company is Rs 13 crore, comprising 1.30 crore equity shares of Rs 10 each.
This is a reshuffling of shares within the promoter family (a gift between husband and wife) and does not change the overall promoter group ownership or control of the company. Existing public shareholders are not affected, and no open-market buying pressure or change in management is implied.